Cargando…
COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316066/ https://www.ncbi.nlm.nih.gov/pubmed/34400057 http://dx.doi.org/10.1016/j.ejca.2021.07.017 |
| _version_ | 1783729808464674816 |
|---|---|
| author | Chen, Yu-Wei Tucker, Matthew D. Beckermann, Kathryn E. Iams, Wade T. Rini, Brian I. Johnson, Douglas B. |
| author_facet | Chen, Yu-Wei Tucker, Matthew D. Beckermann, Kathryn E. Iams, Wade T. Rini, Brian I. Johnson, Douglas B. |
| author_sort | Chen, Yu-Wei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8316066 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83160662021-07-28 COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors Chen, Yu-Wei Tucker, Matthew D. Beckermann, Kathryn E. Iams, Wade T. Rini, Brian I. Johnson, Douglas B. Eur J Cancer Letter to the Editor Elsevier Ltd. 2021-09 2021-07-28 /pmc/articles/PMC8316066/ /pubmed/34400057 http://dx.doi.org/10.1016/j.ejca.2021.07.017 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Chen, Yu-Wei Tucker, Matthew D. Beckermann, Kathryn E. Iams, Wade T. Rini, Brian I. Johnson, Douglas B. COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors |
| title | COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors |
| title_full | COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors |
| title_fullStr | COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors |
| title_full_unstemmed | COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors |
| title_short | COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors |
| title_sort | covid-19 mrna vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316066/ https://www.ncbi.nlm.nih.gov/pubmed/34400057 http://dx.doi.org/10.1016/j.ejca.2021.07.017 |
| work_keys_str_mv | AT chenyuwei covid19mrnavaccinesandimmunerelatedadverseeventsincancerpatientstreatedwithimmunecheckpointinhibitors AT tuckermatthewd covid19mrnavaccinesandimmunerelatedadverseeventsincancerpatientstreatedwithimmunecheckpointinhibitors AT beckermannkathryne covid19mrnavaccinesandimmunerelatedadverseeventsincancerpatientstreatedwithimmunecheckpointinhibitors AT iamswadet covid19mrnavaccinesandimmunerelatedadverseeventsincancerpatientstreatedwithimmunecheckpointinhibitors AT rinibriani covid19mrnavaccinesandimmunerelatedadverseeventsincancerpatientstreatedwithimmunecheckpointinhibitors AT johnsondouglasb covid19mrnavaccinesandimmunerelatedadverseeventsincancerpatientstreatedwithimmunecheckpointinhibitors |